You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HCV GT5

Showing 1 - 25 of 4,313
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatitis C, Cirrhosis Trial (Sofosbuvir/Velpatasvir + Ribavirin, Sofosbuvir/Velpatasvir/Voxilaprevir)

Not yet recruiting
  • Hepatitis C
  • Cirrhosis
  • (no location specified)
Jul 20, 2022

HIV Trial in United States (N332-GT5 gp140 (IM, Bolus), N332-GT5 gp140 (IM, Fractioned), N332-GT5 gp140 (SC, Bolus))

Not yet recruiting
  • HIV
  • N332-GT5 gp140 (IM, Bolus)
  • +7 more
  • San Francisco, California
  • +7 more
Sep 8, 2023

SOF/VEL±RBV: Efficacy and Safety in GT 3 and 6 HCV Patients

Recruiting
  • Hepatitis C
  • Epclusa (sofosbuvir and velpatasvir)
  • Guangzhou, Guangdong, China
    Deparment of Infectious Diseases, the Second Affiliated Hospital
Jul 1, 2021

Hepatitis C Virus Infection, Response to Therapy of Trial in Canada, United States (Test and treat plus peer mentors, Usual

Recruiting
  • Hepatitis C Virus Infection, Response to Therapy of
  • Test and treat plus peer mentors
  • Usual care
  • Birmingham, Alabama
  • +3 more
Dec 9, 2022

Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493, ABT-530)

Completed
Has Results
  • Chronic Hepatitis C
  • +2 more
  • (no location specified)
Jul 9, 2021

Chronic Hepatitis C, Hepatitis C Virus Trial (ABT-493, ABT-530, ribavirin (RBV))

Completed
Has Results
  • Chronic Hepatitis C
  • Hepatitis C Virus
  • (no location specified)
Jul 9, 2021

HCV, Hepatitis C Infection, Genotype 4 Trial (2 DAA, RBV)

Completed
Has Results
  • HCV
  • +2 more
  • (no location specified)
Jul 28, 2021

Hepatitis C Virus Infection Trial (OBV/PTV/r) ± ribavirin (RBV))

Completed
  • Hepatitis C Virus Infection
  • OBV/PTV/r) ± ribavirin (RBV)
  • (no location specified)
May 9, 2020

Gingivitis; Chronic, Oxidative Stress, Inflammation Trial in Rize (GT-MW group (5% Green tea), WT-MW group (5% White tea),EO-MW

Completed
  • Gingivitis; Chronic
  • +2 more
  • GT-MW group (5% Green tea), WT-MW group (5% White tea),EO-MW group (Listerine mouthrinse)
  • CHX-MW group (0.12% CHX, as a positive control group)
  • Rize, Turkey
    Yagmur Sarac Gul
May 6, 2023

Chronic Hepatitis C Trial (Grazoprevir 100 mg/Elbasvir 50 mg fixed-dose combination tablets)

Completed
Has Results
  • Chronic Hepatitis C
  • Grazoprevir 100 mg/Elbasvir 50 mg fixed-dose combination tablets
  • (no location specified)
Jan 15, 2021

Hepatitis C Infection Trial (Grazoprevir + Elbasvir, Ribavirin)

Completed
Has Results
  • Hepatitis C Infection
  • (no location specified)
Jan 15, 2021

Chronic HCV Infection Trial in Clermont-Ferrand (Elbasvir/Grazoprevir Fixed Dose Combination)

Completed
Has Results
  • Chronic HCV Infection
  • Elbasvir/Grazoprevir Fixed Dose Combination
  • Clermont-Ferrand, France
    CHU Clermont-Ferrand
Sep 9, 2020

Chronic HCV Infection Trial in China (HEC74647PA+HEC110114, Placebo)

Recruiting
  • Chronic HCV Infection
  • Bengbu, Anhui, China
  • +35 more
May 24, 2022

Hepatitis C Trial (Grazoprevir, Uprifosbuvir, Elbasvir)

Completed
Has Results
  • Hepatitis C
  • (no location specified)
Jul 18, 2019

Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

Recruiting
  • Acute Bilineal Leukemia
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 24, 2023

Hepatitis C, Chronic Trial in Riyadh (Elbasvir, Grazoprevir 50-100Mg Oral Tablet)

Completed
  • Hepatitis C, Chronic
  • Elbasvir, Grazoprevir 50-100Mg Oral Tablet
  • Riyadh, Saudi Arabia
    King Fahad Medical City
Nov 18, 2020

Untreated Adult Acute Myeloid Leukemia Trial in Houston (Cladribine, Guadecitabine, Idarubicin)

Completed
Has Results
  • Untreated Adult Acute Myeloid Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Apr 28, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (procedure, drug, other)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 6, 2022

Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/pibrentasvir adult formulation, Glecaprevir/pibrentasvir pediatric

Completed
Has Results
  • Hepatitis C Virus (HCV)
  • Glecaprevir/pibrentasvir adult formulation
  • Glecaprevir/pibrentasvir pediatric formulation
  • San Francisco, California
  • +37 more
Sep 19, 2022

Chronic Hepatitis C Infection Trial in Beijing, Hong Kong (PR4 + LDV/SOF + ASV 4 wk, PR4 + LDV/SOF + SMV 4 wk, PR4 + LDV/SOF +

Recruiting
  • Chronic Hepatitis C Infection
  • PR4 + LDV/SOF + ASV 4 wk
  • +7 more
  • Beijing, Beijing, China
  • +1 more
Aug 27, 2021

Chronic Hepatitis C Virus (HCV) Infection Genotype 1 Trial in United States (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))

Completed
Has Results
  • Chronic Hepatitis C Virus (HCV) Infection Genotype 1
  • Phoenix, Arizona
  • +47 more
Jun 27, 2022

HCV-TARGET- Hepatitis C Therapeutic Registry and Research

Active, not recruiting
  • Hepatitis C
    • Phoenix, Arizona
    • +59 more
    Oct 5, 2022

    Aortic Valve Disease, Aortic Valve Disorder Trial in Worldwide (Trifecta GT (Glide Technology) Valve)

    Active, not recruiting
    • Aortic Valve Disease
    • Aortic Valve Disorder
    • Trifecta GT (Glide Technology) Valve
    • Rochester, Minnesota
    • +26 more
    Mar 10, 2022

    Hepatitis C, HCV Trial in San Antonio (TD-6450, Placebo)

    Completed
    • Hepatitis C
    • HCV
    • San Antonio, Texas
      Texas Liver Institute
    Jan 15, 2021

    Primary Myelofibrosis, Secondary Myelofibrosis Trial in Seattle (procedure, drug, other, radiation)

    Active, not recruiting
    • Primary Myelofibrosis
    • Secondary Myelofibrosis
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +11 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 10, 2023